Head & Neck

Advanced:

CIRB #H-29284/RTOG #R0920: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab For Locally-Advanced Resected Head and Neck Cancer

IRB #H-33141/CTSU #E3311: A Phase II Randomized Trial of Transoral Surgical Resection followed by Low-dose or Standard-dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

IRB #H-33823/NRG #HN002: A Randomized Phase II Trial for Patients with P16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer

High Risk:

CIRB #H-32379/RTOG #R1216: Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered With Concurrent Cisplatin versus Docetaxel versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck Salivary Gland Tumors:

Nasopharyngeal:

CIRB #H-33148/NRG# HN001: Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)

Primary teaching affiliate
of BU School of Medicine